MedChemExpress (MCE), a leading global supplier of high-quality life science reagents, is headquartered in the U.S. with 10 warehouses across the world.

MCE manufactures over 100,000 specific inhibitors and agonists that target more than 1,000 proteins across 20+ signaling pathways (e.g., cancer, immunology, neuroscience), supported by industry-leading data, including clinical status, solubility measurements, and stringent QC reports (NMR, HPLC). MCE offers custom synthesis solutions (ADCs, PROTACs, oligonucleotides) and a one-stop drug discovery platform that features 200+ specialized compound libraries and advanced services: DNA-encoded library screening, high-throughput screening, kinase profiling, custom synthesis, and structural optimization.

MCE provides 12,000+ recombinant proteins, 4,000+ dyes, and exclusive compounds backed by a professional team tracking pharmaceutical breakthroughs. Empower your research with innovative tools and end-to-end solutions for biopharmaceutical development.

MCE has implemented ISO 9001:2015 as the foundational framework for a comprehensive quality management system. Building upon this foundation, MCE has achieved more stringent certifications, including ISO 17025 and CNAS, and has successfully passed rigorous cGMP inspection by regulatory authorities. Besides, MCE adheres to stringent ESG standards and maintains recognized qualifications, including ISO 14001, ISO 45001, and the premium EcoVadis rating.

Country of Origin: USA